One of the longstanding challenges in chemical biology has been finding ways to directly observe biological processes at work ...

After a three-year drought, the industry is questioning whether the window for medtech public offerings is open following a ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...